A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...

Research at Stanford Medicine suggests that a urine test may. be able to determine which patients will benefit from additional therapy.

Pfizer (NYSE:PFE) received U.S. FDA Priority Review for a supplemental Biologics License Application covering PADCEV plus ...

Qlucore, listed on Nasdaq First North, is launching a new Qlucore Insights test (Research Use Only) specifically developed for bladder cancer samples. The software-based test delivers multiple ...

Groundbreaking study published in The Journal of Molecular Diagnostics paves the way for noninvasive screening tools that improve patient comfort and outcomes Bladder cancer remains a major clinical ...

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample can effectively diagnose and stage bladder cancer, offering a much-needed ...

New Urine Test Could Predict Response To Bladder Cancer Treatment. Researchers have developed a urine test that can screen for tumor DNA and detect whether a patient has residual bladder cancer after ...

Doctors are urging the public to seek medical advice when abnormal symptoms arise, following the death of local marathoner ...

The extent of the bladder cancer — how far it has spread — matters. Your care team needs to know if your cancer sits on or in the first lining of your bladder (non-muscle invasive), if it goes into ...

Signatera detects molecular residual disease in bladder cancer by identifying tumor DNA fragments in the bloodstream, even when not visible on scans. The IMvigor010 trial showed that Signatera-guided ...